Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder | MicrobiomeTrials← Back to trialsNCT06142955
Transcranial Magnetic Stimulation (TMS) to Treat Depression in Autism Spectrum Disorder
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2024-04-30Est. Completion: 2027-02
Enrollment target: 60 participants Locations- Yale Psychiatric Hospital, New Haven, Connecticut, United States
Other microbiome trials you might be interested in
Autism Spectrum DisorderFood Selectivity
The goal of this randomized, single-blind clinical trial is to evaluate the effectiveness of the Exploradores de Sabores…
Tijuana, MexicoEst. completion Dec 2026
Autism Spectrum Disorder (ASD)
The goal of this sequential multiple assignment randomized trial is to conduct a preliminary evaluation of Our Love, Our…
Seoul, South KoreaEst. completion Mar 31, 2028
Neuropsychiatric DisorderNeurological DisorderNeurodevelopmental DisorderSleep
Background:
\- Many psychiatric, behavioral, and developmental disorders are genetic. This means that they tend to run …
Bethesda, United StatesEst. completion Feb 20, 2029